892711-75-0
892711-75-0
Chemical Structure
CDN1163
- CAS No.: 892711-75-0
- Formula:C20H20N2O2
- Molecular Weight:320.39
IUPAC Name: 4-isopropoxy-N-(2-methylquinolin-8-yl)benzamide
InChIKey: GVGVYDCVFBGALZ-UHFFFAOYSA-N
SMILES: O=C(NC1=C2N=C(C)C=CC2=CC=C1)C3=CC=C(OC(C)C)C=C3
Biological Activity: CDN1163 is an allosteric sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) activator that improves Ca2+ homeostasis. CDN1163 attenuates diabetes and metabolic disorders[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDN1163 | 99.84% | CDN1163 is an allosteric sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) activator that improves Ca2+ homeostasis. CDN1163 attenuates diabetes and metabolic disorders. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
CDN1163 (Standard) | ≥98% | CDN1163 (Standard) is the analytical standard of CDN1163 (HY-101455). This product is intended for research and analytical applications. CDN1163 is an allosteric sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) activator that improves Ca2+ homeostasis. CDN1163 attenuates diabetes and metabolic disorders. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
